Mira Pharmaceuticals (MIRA) Total Debt (2022 - 2026)
Mira Pharmaceuticals (MIRA) total debt from Dec 31, 2022 to Mar 31, 2026. The current Mira Pharmaceuticals (MIRA) total debt is $110K. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Total Debt
Total Debt
Mira Pharmaceuticals (MIRA) Total Debt CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -48.71% |
| 3 Years TTM | -6.37% |
| All Time TTM | -42.26% |
Annual Total Debt change of Mira Pharmaceuticals (MIRA)
| Year | Total Debt | Change |
|---|---|---|
| 2025 | $700K | -2.78% |
| 2024 | $720K | +28.57% |
| 2023 | $560K | -61.38% |
| 2022 | $1.45M | N/A |
Comparison Mira Pharmaceuticals (MIRA) total debt with competitors
Mira Pharmaceuticals (MIRA) total debt is $110000.00.
| Ticker | Name | Total Debt | Upside |
|---|---|---|---|
| NSRX | Nasus Pharma Ltd | $2.24M | +1932.73% |
| MDCX | MDCorp | $6.00M | +5353.65% |
| MDCXW | Medicus Pharma Ltd warrant | $6.00M | +5353.65% |
| AMRN | Amarin Corp | $196.35M | +178400.91% |
| SCLX | Scilex Holding Company | $547.71M | +497813.64% |
| BIIB | Biogen Inc | $10.83B | +9846627.27% |
| OGN | Organon & Company | $12.09B | +10993536.36% |
| GRFS | Grifols SA | $12.24B | +11130586.81% |
| SNY | Sanofi | $54.88B | +49891718.18% |
| GSK | GSK Plc | $59.93B | +54482590.00% |
| BMY | Bristol-Myers Squibb Company | $66.37B | +60339900.00% |
| AZN | Astrazeneca plc | $66.63B | +60573536.36% |
| NVS | Novartis AG | $79.61B | +72368081.82% |
| PFE | Pfizer Inc | $117.21B | +106558081.82% |
| JNJ | Johnson & Johnson | $119.71B | +108825354.55% |
| NVO | Novo Nordisk | $356.16B | +323778081.82% |